40 Participants Needed

Reverse vs Anatomic Shoulder Replacement for Shoulder Osteoarthritis

(CERVASA Trial)

Recruiting at 7 trial locations
LB
AS
AR
Overseen ByAilar Ramadi, PhD
Age: 65+
Sex: Any
Trial Phase: Academic
Sponsor: University of Alberta
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial compares two types of shoulder surgery, Reverse Total Shoulder Arthroplasty (RTSA) and Total Shoulder Arthroplasty (TSA), for individuals with severe shoulder osteoarthritis. The researchers aim to determine which surgery provides better outcomes in function and quality of life, while also resulting in fewer complications within the first year post-surgery. Suitable candidates have experienced shoulder pain and disability for at least six months despite treatments such as medication and physiotherapy. As an unphased trial, this study allows patients to contribute to valuable research that could enhance future treatment options for shoulder osteoarthritis.

Do I need to stop my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research shows that Reverse Total Shoulder Arthroplasty (RTSA) is generally well-tolerated by older adults with osteoarthritis. Studies have found that it can greatly improve shoulder movement and reduce pain. However, some patients may experience problems with the shoulder implant, such as loosening or infection.

For Total Shoulder Arthroplasty (TSA), evidence suggests it also improves shoulder function and relieves pain. It is considered effective for people with shoulder arthritis. While complications can occur, they are usually manageable.

Both procedures have been safely used in many patients. Although each has its own risks, they are generally considered safe for treating advanced shoulder osteoarthritis in older adults.12345

Why are researchers excited about this trial?

Researchers are excited about these treatments because they offer new approaches to shoulder osteoarthritis. Reverse Total Shoulder Arthroplasty (RTSA) is unique because it reconfigures the shoulder's anatomy by switching the ball-and-socket positions. This allows for better stability and function, especially in cases where rotator cuff muscles are compromised. On the other hand, Total Shoulder Arthroplasty (TSA) aims to restore the shoulder's natural anatomy, which can help improve the joint's alignment and function. Both techniques utilize advanced imaging and software for precise surgical planning, offering promising improvements over traditional shoulder replacement methods.

What evidence suggests that this trial's treatments could be effective for shoulder osteoarthritis?

This trial will compare Reverse Total Shoulder Arthroplasty (RTSA) with Total Shoulder Arthroplasty (TSA) for treating shoulder osteoarthritis. Research has shown that RTSA can greatly improve shoulder movement and reduce pain, particularly for individuals aged 60 and older, offering relief similar to other shoulder replacement surgeries. TSA also reduces pain and enhances shoulder function and is often recommended for patients with healthy rotator cuffs. Both RTSA and TSA offer significant benefits, but their suitability may vary based on the patient's shoulder condition and age.12467

Are You a Good Fit for This Trial?

This trial is for people aged 65 and older with advanced shoulder osteoarthritis who haven't improved after 6 months of non-surgical treatments like painkillers, anti-inflammatory drugs, and physiotherapy. It's not suitable for those with significant muscle paralysis, major illnesses limiting life expectancy or surgical risk, active compensation claims, previous shoulder surgery on the affected side, infections, certain joint conditions or psychiatric issues affecting consent.

Inclusion Criteria

I am undergoing physiotherapy with exercises and treatments like ultrasound.
My shoulder socket has a deficiency and is tilted backward more than 15 degrees.
I still have pain and disability after 6 months of standard treatment without surgery.
See 6 more

Exclusion Criteria

You have a mental health condition that affects your ability to understand and make informed decisions.
I have had shoulder surgery on the same side as my current condition.
I am not willing to participate in follow-up visits for the study.
See 9 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
1 visit (in-person)

Baseline Evaluation

Baseline measurements of shoulder range of motion, strength, and quality of life questionnaires are collected

1 week
1 visit (in-person)

Treatment

Participants undergo either Total Shoulder Arthroplasty (TSA) or Reverse Total Shoulder Arthroplasty (RTSA)

Surgery and immediate post-operative care
1 visit (in-person)

Post-operative Evaluation

Post-operative evaluations at 6 weeks, 3, 6, and 12 months to assess shoulder function and quality of life

12 months
4 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Reverse Total Shoulder Arthroplasty (RTSA)
  • Total Shoulder Arthroplasty (TSA)
Trial Overview The study compares two types of shoulder replacement surgeries in patients over 65 with severe osteoarthritis: Total Shoulder Arthroplasty (TSA) and Reverse Total Shoulder Arthroplasty (RTSA). Participants will be randomly assigned to one of these procedures to see which offers better function and quality of life outcomes within a year post-surgery.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Reverse Total Shoulder Arthroplasty (RTSA)Experimental Treatment1 Intervention
Group II: Total Shoulder Arthroplasty (TSA)Active Control1 Intervention

Reverse Total Shoulder Arthroplasty (RTSA) is already approved in European Union, United States for the following indications:

🇪🇺
Approved in European Union as Reverse Total Shoulder Arthroplasty for:
🇺🇸
Approved in United States as Reverse Total Shoulder Replacement for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Alberta

Lead Sponsor

Trials
957
Recruited
437,000+

University Hospital Foundation

Collaborator

Trials
8
Recruited
1,800+

Canadian Orthopaedic Foundation

Collaborator

Trials
15
Recruited
1,900+

Published Research Related to This Trial

In a study of 36 patients who underwent shoulder arthroplasty, both total shoulder arthroplasty (TSA) and reverse total shoulder arthroplasty (RTSA) showed similar patterns of shoulder motion, with no significant differences in motion frequency between the two procedures.
Most shoulder movements occurred below 80° of elevation, with TSA patients averaging 821 motions per hour and RTSA patients averaging 783 motions per hour, indicating that both procedures effectively restore shoulder function without significant differences in performance.
Comparing daily shoulder motion and frequency after anatomic and reverse shoulder arthroplasty.Langohr, GDG., Haverstock, JP., Johnson, JA., et al.[2018]
In a study of 19,497 patients, those undergoing reverse total shoulder arthroplasty (RTSA) experienced significantly higher rates of perioperative complications, including mortality, pneumonia, and deep venous thrombosis, compared to those who had total shoulder arthroplasty (TSA).
RTSA patients also had longer hospital stays and higher hospital charges, with an average increase of $11,530, indicating that RTSA may carry greater risks and costs than TSA, even after adjusting for patient comorbidities.
Analysis of perioperative complications in patients after total shoulder arthroplasty and reverse total shoulder arthroplasty.Jiang, JJ., Toor, AS., Shi, LL., et al.[2022]
This case series reports a previously unrecognized complication of humeral tray-taper failure in patients who underwent modular reverse total shoulder arthroplasty (RTSA), with five patients experiencing this issue out of 300 total cases over seven years.
Dynamic fluoroscopy was effective in diagnosing the failure, and all patients who underwent revision surgery to a second-generation humeral tray experienced symptom relief, indicating that while the complication is serious, effective treatment options are available.
Humeral Tray-Taper Failure in Modular Reverse Total Shoulder Arthroplasty.McDonald, LS., Dines, JS., Chin, C., et al.[2020]

Citations

Long-Term Outcomes Following Reverse Total Shoulder ...RTSA appears to provide substantial long-term improvements in shoulder function, clinical outcomes, and pain relief, albeit with significant complication and ...
Reverse total shoulder replacement versus anatomical ...This study's findings provide reassurance that RTSR is an acceptable alternative to TSR for patients aged 60 years or older with osteoarthritis and intact ...
Glenohumeral osteoarthritis and reverse shoulder ...This article aims to provide a comprehensive review of the role of rTSA in the treatment of glenohumeral osteoarthritis, highlighting a series of reported ...
Total vs. Reverse Shoulder Replacement: Pain Relief Two ...The Reverse Shoulder Arthroplasty has revolutionized the management of complex shoulder pain and dysfunction due to rotator cuff tear arthropathy since its FDA ...
Shoulder replacement in the under 55's is anatomical or ...ASA consistently emerges as the superior choice for younger patients with well-preserved rotator cuffs and minimal anatomical compromise.
A systematic review and meta-analysisOur meta-analysis indicates that, for shoulder degenerative diseases, aTSA generally offers superior postoperative efficacy compared with rTSA.
An update on reverse total shoulder arthroplastyNumerous studies have reported on outcomes for revision of shoulder arthroplasty to RTSA. They report satisfactory functional outcomes, but with ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security